ArticleBMJ open diabetes research & care2016

Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial.

Kohjiro Ueki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.